科华生物：控股子公司基孔肯雅热病毒RNA检测试剂盒尚未申请医疗器械注册证

Core Viewpoint - The company, Kehua Bio-engineering, has stated that its subsidiary, Xi'an Tianlong, has not applied for the National Medical Products Administration's medical device registration for its chikungunya virus RNA detection kit, which is currently only available as a research reagent for customs and disease control applications [1] Group 1 - The chikungunya virus RNA detection kit is based on fluorescent PCR technology [1] - The company is monitoring market demand closely and plans to develop a product registration strategy aligned with its business needs and development strategy [1] - The company aims to actively seize related business opportunities in the future [1]